Cargando…
Cell-Based Small-Molecule Compound Screen Identifies Fenretinide as Potential Therapeutic for Translocation-Positive Rhabdomyosarcoma
A subset of paediatric sarcomas are characterized by chromosomal translocations encoding specific oncogenic transcription factors. Such fusion proteins represent tumor specific therapeutic targets although so far it has not been possible to directly inhibit their activity by small-molecule compounds...
Autores principales: | Herrero Martín, David, Boro, Aleksandar, Schäfer, Beat W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555977/ https://www.ncbi.nlm.nih.gov/pubmed/23372815 http://dx.doi.org/10.1371/journal.pone.0055072 |
Ejemplares similares
-
Fenretinide Acts as Potent Radiosensitizer for Treatment of Rhabdomyosarcoma Cells
por: Brack, Eva, et al.
Publicado: (2021) -
Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule
por: Potenza, Rosa Luisa, et al.
Publicado: (2022) -
DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma
por: Virgone, Calogero, et al.
Publicado: (2015) -
High Frequency of Tumor Propagating Cells in Fusion-Positive Rhabdomyosarcoma
por: Generali, Melanie, et al.
Publicado: (2021) -
The protective effect of fenretinide against allergic asthma
por: Kanagaratham, Cynthia, et al.
Publicado: (2010)